ALAB
Astera Labs, Inc. Common Stock
ALAB's outlook is improving, though it still trails on the overall score.
PLTR
Palantir Technologies Inc.
PLTR has the edge over ALAB overall, supported by stronger valuation and lower modeled downside.
ALAB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
ALAB's revenue, profitability, cash flow and balance sheet are all currently strong.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
ALAB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 33x | $228 | — |
| Cheap | 72x | $182 | -20% |
| Current | 91x | $228 | — |
| Fair | 108x | $272 | +19% |
| Expensive | 172x | $431 | +89% |
Historical ranges are pointers, not guarantees.
ALAB's PE is in its fair range at 91x. If earnings grow as analysts expect, today's price would be 33x next year's earnings, in its cheap range.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over ALAB in the historical PE scenario, which offers more potential upside but is not a forecast.
ALAB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for ALAB, with profitability improving.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for PLTR, with profitability improving.
ALAB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.88 | +174% |
| Q3 2026 | $2.51 | +14% |
| Q2 2026 | $2.02 | +22% |
| Q1 2026 | $1.48 | +13% |
| Q4 2025 | $1.22 | +$1.86 |
| Q3 2025 | $2.20 | +$3.98 |
| Q2 2025 | $1.65 | +$3.40 |
| Q1 2025 | $1.31 | +$3.16 |
| Q4 2024 | -$0.64 | -$0.43 |
ALAB earned $2.51 per share over the past year, up 14% from the year before.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over ALAB on earnings, with more consistent year-over-year improvement.
ALAB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $584.9M | +154% |
| Q2 2026 | $392.4M | +104% |
| Q1 2026 | $308.4M | +93% |
| Q4 2025 | $270.6M | +92% |
| Q3 2025 | $230.6M | +104% |
| Q2 2025 | $191.9M | +150% |
| Q1 2025 | $159.4M | +144% |
| Q4 2024 | $141.1M | +179% |
ALAB has the edge over PLTR on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | +6.6 points |
| Q2 2026 | 23% | +2 points |
| Q1 2026 | 20% | +13 points |
| Q4 2025 | 25% | +25 points |
| Q3 2025 | 24% | +32 points |
| Q2 2025 | 21% | +52 points |
| Q1 2025 | 7.1% | +134 points |
| Q4 2024 | 0.1% | -18 points |
ALAB's operating margin was 31% last quarter, up 6.6 points from the same quarter a year ago, near the top of its range since 2022.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR's revenue has grown year over year every quarter since late 2020: $2.3B last quarter, up 96% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over ALAB on profitability, with a higher operating margin.
ALAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $133.9M | +103% |
| Q2 2026 | $67.2M | -50% |
| Q1 2026 | $67M | +1023% |
| Q4 2025 | $76.6M | +216% |
| Q3 2025 | $65.9M | +41% |
| Q2 2025 | $133.3M | +328% |
| Q1 2025 | $6M | +2516% |
| Q4 2024 | $24.3M | +81% |
ALAB generated $345M in free cash flow over the past year, up 50% from the year before.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR generated $4.1B in free cash flow over the past year, up 126% from the year before.
ALAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +737K shares |
| 1 year | +1.9% | +3.4M shares |
| 3 years | +21% | +31.6M shares |
ALAB has 184M diluted shares, up 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | $210,000 |
| Q3 2023 | — |
| Q2 2023 | $118,000 |
| Q1 2023 | — |
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has the edge over ALAB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
ALAB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -3.5x | Net Cash |
ALAB has more cash than debt.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has the edge over ALAB on leverage, with a lower net debt burden relative to earnings.
ALAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.1 | Neutral |
| Stochastic | 12.4 | Oversold |
ALAB's weekly RSI is 43 (neutral) and its Stochastic is 12 (oversold).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
ALAB PE vs Technology Sector
| Metric | ALAB | Sector median | Relative |
|---|---|---|---|
| PE | 91x | 28x | 226% above |
| PE % | 33 | 17 | 16 pts above |
ALAB has the edge over PLTR on valuation relative to its sector.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
ALAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $284.7 | 20% below |
| 20 week MA | $306.9 | 26% below |
| 50 week MA | $241.4 | 5.6% below |
| 100 week MA | $182.7 | 25% above |
PLTR has stronger trend alignment. ALAB is above 1 of 4 weekly averages versus PLTR above 4 of 5.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR's trend is up, with a small recent dip: it's below only its 8-week average, and 106% above its 200-week average.
ALAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $70.0 | $141.5 | +102% |
| 2025 | $141.5 | $167.3 | +18% |
| 2026 YTD | $167.3 | $227.8 | +36% |
ALAB has the edge over PLTR on returns for 2026, with the stronger performance.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR's yearly returns have swung widely, from +361% in 2024 to −67% in 2022. It's down 9.1% so far in 2026.